INTRODUCTION
Biospecimens provide researchers with the bases for measuring biologic, pharmacologic, and response differences among racial/ethnic populations, thus offering great potential for personalized medicine approaches. [1] [2] [3] Increasing the number and proportion of biospecimens from racial/ethnic minority populations is essential to developing more effective cancer treatments for those groups and, in the long term, is essential to reducing cancer health disparities. 4 To ensure that Asian Americans-the fastest-growing racial/ethnic group in the United States 5, 6 and the first US racial/ethnic group to experience cancer as the leading cause of death 7, 8 -are participating in donating biospecimens for cancer research, the Asian American Network for Cancer Awareness and Training (AANCART) and the National Center for Reducing Asian American Cancer Health Disparities have developed the Asian American Cancer Education Study (AACES). The goal of AACES was to increase the number and proportion of blood biospecimens donated for cancer research from Asian Americans through community engagement, outreach, and in-reach (within the institution) and through education.
In the AACES, we first examined individual factors associated with Asian Americans' willingness to donate biospecimens for cancer research. Like other studies, we discovered that, although Asian Americans had low levels of awareness and knowledge regarding biospecimen donation and biobanking, interventions that increased knowledge of and fostered more favorable attitudes toward biospecimen donation resulted in a greater willingness to donate. [9] [10] [11] [12] Common barriers to donation include: cultural beliefs about biospecimens, such as the belief that there is a finite amount of blood in the body and, once that blood leaves the body, it will not be replenished; not being asked to donate; and distrust of research. [9] [10] [11] [12] Common facilitators to donating include altruism and wanting to benefit future generations. [9] [10] [11] [12] However, although we identified common factors that influence Asian American's decision to donate biospecimens, we also observed ethnic specific differences. For example, our needs assessment revealed that Chinese, Hmong, and Vietnamese respondents not only differed in the perceived benefits and their perceived barriers for donating biospecimens, but they also differed in terms of the setting they believed was most conducive for providing biospecimens. 10, 13, 14 On the basis of our formative research and a review of the literature, we recognize that there is considerable heterogeneity within the Asian American community and that a 1-size-fits-all approach to engaging the Asian American community in biospecimen donation would not work. Thus we developed targeted community engagement and outreach campaigns tailored to each respective ethnic group: Chinese, Hmong, and Vietnamese. Our assumption was that Asian Americans would donate blood biospecimens if researchers first established a foundation of trust by being transparent in their research endeavors and by committing the time necessary to build community capacity for biospecimen donation, and then provided Asian Americans with an opportunity to donate.
The objective of this report is to describe our approach and to report findings with regard to increasing blood biospecimens donations for cancer research from both the general Asian American community and from Asian American patients with cancer. Our approach included 2 types of community engagement: outreach and in-reach. Outreach refers to the approach we used with the general Asian Americans community, and inreach refers to the approach we used with Asian American cancer patients within our own institution.
MATERIALS AND METHODS

AACES Timeframe
AACES began in January 2010 and ended June 2016. From January 2010 to December 2011, we conducted formative research on factors that influence Asian Americans' decision to donate biospecimens for cancer research and, based on those findings, developed inlanguage, culturally appropriate biospecimen education material (videos and brochures) in Cantonese, Hmong, Korean, Mandarin, and Vietnamese. From January 2012 to August 2014, we held community biospecimen blood drives to recruit the general Asian American community to donate blood biospecimens for cancer research; and, from August 2014 to June 2016, we recruited Asian American patients with cancer at the University of California, Davis (UCD) Comprehensive Cancer Center (CCC). In the current report we focus on the period from January 2012 through June 2016, when we recruited Asian Americans to donate only blood biospecimens. Results from the AACES needs assessment, pilot studies, and development of educational materials have been presented elsewhere. 10, 13, 14 This study was approved by the UCD Institutional Review Board. All participants were consented in their language of preference, and all blood biospecimens donated were processed and stored at the UCD Biorepository, a Cancer Center Support Grant Shared Resource. Study activities occurred in Sacramento, California, a city located in the UCD CCC primary catchment area. Participants received a $10 gift card that was redeemable at a local supermarket.
Outreach
Study sites and design
Through AANCART, we have developed and fostered a decade-long relationship with the Chinese, Hmong, and Vietnamese communities of Sacramento, California. We used those relationships to approach and engage these communities in biospecimen donation. For the Hmong community, we collaborated with a local Hmong community-based organization, the Hmong Women's Heritage Association; and, for the Chinese and Vietnamese communities, we collaborated with 2 UCD studentrun medical clinics, Paul Hom Asian Clinic and the Vietnamese Cancer Awareness Research Education Society Clinic. We have partnered with Hmong Women's Heritage Association, Paul Hom Asian Clinic, and the Vietnamese Cancer Awareness Research Education Society Clinic on numerous cancer control and prevention projects, including conduct of the formative AACES research and the development of biospecimen educational materials. In addition to collecting blood biospecimens for future cancer research, we also collected blood biospecimens to test for hepatitis B virus and diabetes (using the hemoglobin A1c test) to assess the prevalence of these 2
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Our outreach approach was to work with our community partners to provide biospecimen education to their respective communities and, second, to host community biospecimen blood drives to recruit interested individuals to donate. All engagement, outreach, and educational activities were provided in both English and in the native language of the participants. A flowchart of our outreach community engagement strategy is provided in Figure 1 .
Screening and recruitment
Participants in the community biospecimen blood drive were recruited through our collaborating organizations and ethnic media (newspaper advertisements and radio advertisements). All participants who donated blood biospecimens were required to be at least age 18 years. Participants also filled out a short survey regarding their age, sex, and country of birth.
Community biospecimen blood drives
Similar in concept to a blood drive, we held community biospecimen blood drives to offer interested individuals the opportunity to donate blood biospecimens on site and at a location convenient to them. These drives typically lasted between 2 to 3 hours and were held in conjunction with health-promotion activities sponsored by the collaborating organizations (ie, health fairs, health screenings, community forums, etc) and at community-based venues (ie, community centers, churches, temples, community health clinics, at the offices of the community-based organizations, etc).
During these health-promotion activities, our health educators would approach potential participants and engage them in a conversation (in the language of preference of the participant) regarding biospecimen donation. If the individual agreed to participate, then the health educator would consent them and help them complete the short survey. A phlebotomist would than draw the participant's blood, and staff from the UCD CCC Biorepository would collect the donated blood biospecimen and transported it back to the UCD CCC Biorepository. For each participant, the entire process took approximately 15 to 20 minutes to complete. Participants had the option of donating 1, 2, or 3 tubes of blood (3.5 mL each) for either hepatitis B testing, hemoglobin A1c testing, and/or future cancer research. In addition, participants had the option of whether they wanted to be contacted with the results from the hepatitis B and/or hemoglobin A1C test.
Once the blood was transported back to UCD CCC, depending on what the participant consented to donating, the blood was either processed by the laboratory for the appropriate testing and/or was given to the biorepository to be spun down into plasma and serum, coded, and stored in the biorepository freezer.
In-Reach
Study sites and design
We worked with UCD CCC providers and staff to develop a protocol that would allow us to approach and engage Asian American patients with cancer in biospecimen donation. Our approach had 3 main components: first, we had to set up a standing monthly report to get a list of all Asian American patients who had an upcoming appointment at the UCD CCC; next, we contacted the patient and invited them to come to their appointment times 30 minutes early to learn more about biospecimen donation; and finally, for those who did arrive early, we educated them on donating biospecimens and, after the education session, asked them whether they would consent to donating an extra tube of blood for cancer research at each of their next routine blood draws as a patient. For a flowchart of our in-reach community engagement strategy, see Figure 1 .
Screening and recruitment
We worked with the UCD Health Clinical and Translational Science Center Biomedical Informatics team to use our electronic health system to generate an automated monthly report of all the Asian American patients who had an upcoming UCD CCC appointment. This report was created by developing an algorithm that identified Asian American patients by the 50 most common surnames for each ethnicity 15 and by self-reported race/ethnicity. We focused only on patients for whom we had health educators who could provide in-language education (Chinese, Hmong, and Vietnamese) and on Asian American patients who listed English as their preferred language. This monthly report included each patient's contact information (address and telephone number), scheduled appointment date and time, and preferred language. We excluded all new Asian American patients so that their providers would be able to establish a relationship with them first. In addition, we did not review the patient's electronic medical record, thus we chose not to know the reason for their visit or the stage of their treatment.
Biospecimen educational sessions
Only providers who gave consent for their patients to be included in the AACES were invited to be part of this study. Two weeks before a patient had a scheduled appointment, research staff mailed the patient a letter letting them know that a health educator would meet with them in the reception area 30 minutes before their appointment time to talk to them about donating biospecimens for cancer research. In addition to the letter, patients received a tri-fold biospecimen brochure with English on 1 side and the patient's preferred language on the other side (if not English).
On the day of the appointment, a health educator arrived at the stated time and checked in with the front desk staff to see whether the patient had arrived. If the patient had arrived, then the health educator approached the patient and asked them whether they were interested in learning about biospecimen donation. If the patient had not arrived, the health educator waited in the reception area until they did arrive and then proceeded to ask them whether they wanted to participate. If the patient was not interested, then the health educator thanked them for their time and gave them a business card in case they wanted to participate at a later time. If the patient agreed to participate, then the health educator had the patient view a 5-minute biospecimen educational video on an iPad in the patient's preferred language. The health educator next proceeded to answer any questions participants had regarding donating. Educational sessions usually lasted approximately 15 to 30 minutes; and, after the session was over, the health educator asked the patient whether they would like to donate an extra tube of blood during their next routine blood draw for cancer research.
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If the patient agreed, then the team member would consent them. All consent forms were then handed over the UCD CCC Biorepository staff, who entered an order on the patient's electronic medical record indicating that the patient had agreed to donate an extra tube of blood for cancer research at each of their next routine blood draws.
Time
AANCART has partnered with the Asian American community of Sacramento, California, since 2002, when AANCART's headquarters moved there from Columbus, Ohio. This partnership has led to many collaboration over the years, not only to increase cancer awareness, prevention, and control in the community but also to build capacity and facilitate community-based, participatory research. 16 We partnered with the Sacramento Hmong community on 2-year to 5-year randomized controlled trials to increase hepatitis B testing 17 and colorectal cancer screening 18 ; and, with the Vietnamese and Chinese communities, we collaborated on a 3-year project to increase hepatitis B testing. 19 These partnerships, established over a decade, represent our commitment to this community. Our ability to approach and engage the Asian American community on the topic of biospecimen donation stems from the time we have devoted to earning the trust of the community.
In terms of our in-reach, we wanted to be mindful of the patient's time; therefore, we started an AACES in the community and contacted patients who had previously participated in our educational sessions and had received the materials we developed. The same values that motivated the community to donate (benefiting future generations) and the approach used (health educators and a direct opportunity to donate) resulted in the recruitment of both patients with cancer and the general community.
Trust
Central to the responsiveness of our participants is earning their trust. In our case, that trust was earned by nearly a decade of working in the local Asian American community through AANCART. We acknowledge that not everyone will have a decade of community partnership to cultivate trust; however, we believe that trust was also earned through using bilingual and bicultural health educators to provide the biospecimen education and through cohosting biospecimen blood drives with local, trusted, communitybased organizations. Those organizations serve as gatekeepers to their communities; and, by engaging them, at the start of the study, we received their full support. Not only was trust earned through the longevity of partnerships and collaborations; we also believe trust must continue to be earned at every event and that the research team must be transparent about their research endeavors.
Transparency
Along with others, we have cited mistrust as a significant barrier to engaging diverse communities in biospecimen donation. 10, 20 Similarly, mistrust of the research being conducted can be avoided by having researchers commit to being upfront and transparent to the community about their research objectives. 20 In our approach, we observed that, by inviting the community to be a part of the research team, we could overcome issues around mistrust. The community was assured that our processes were transparent, because they were given full disclosure of our research. They provided input in the design of the study, assisted in the development of our engagement strategies, and reviewed all of our study documents (eg, the consent forms, educational materials, survey questions, and protocol).
RESULTS
In total, 388 Asian Americans donated 1127 blood biospecimens for cancer research (359 from outreach and 29 from in-reach). Four hundred twenty tubes of plasma and serum are currently being stored for future cancer research in the UCD CCC Biorepository, 39 blood biospecimens have been used for cancer genomic research, and 668 have been used for laboratory testing of hepatitis B and diabetes. The majority of donors were between ages 18 and 29 years (33%), women (66.8%), and foreign-born (53.9%).
Outreach Versus In-Reach
We hosted 10 community biospecimen blood drives (5 in the Hmong community and 5 in the Chinese/Vietnamese community). At these drives, in total, 359 Asian American community members donated 1068 blood biospecimens for cancer research. The majority of donors were Hmong (48.2%), between the ages 18 and 29 years (34.8%), women (66.9%), and foreign-born (53.8%). In terms of in-reach, a total of 29 Asian American cancer patients donated 59 biospecimens for cancer research. Research staff contacted 117 patients and enrolled 34 into AACES. After receiving the education session, 29 patients (85%) consented to donate blood biospecimens for cancer research. Thirteen of those 29 patients have already donated (59 serum and plasma biospecimens), and the remaining 16 have orders for blood draws in their electronic medical records. The majority of donors were women (65.5%), aged 60 years (62.1%), Chinese (34.5%), and foreign-born (55.2%) ( Table 1) .
DISCUSSION
To the best of our knowledge, AACES has collected 1 of the largest numbers of blood biospecimens from Asian Americans (community members and patients with cancer) for cancer research. Our approach, building on our formative research and the literature, demonstrates that Asian Americans are willing to participate in biospecimen collection. By incorporating culturally and linguistically appropriate, ethnically specific, and cognitively empowering educational materials and strategies into our approach, we were able to appropriately address the potential cognitive (ie, language, lack of knowledge), cultural (ie, significance of biospecimens), and social (ie, research mistrust) issues surrounding biospecimen donation. 21 We discovered that, once participants understand how blood biospecimens can be used to further cancer research and improve health outcomes for future generations, the majority are willing to donate despite their initial hesitance if they are given an opportunity to donate.
Cognitively, the first issue we encountered was with translating the term biospecimen appropriately into the different Asian languages, because there are not Asian language equivalents for the term. After consulting with the communities, we decided that, instead of trying to technically translate biospecimen into the different languages, we would give examples of the types of biospecimens individuals could donate instead (eg, blood, hair, saliva, urine, toe nail clippings, etc). In addition, historically and culturally speaking, traditional Chinese, Hmong, and Vietnamese view blood as a source of life or vitality; thus blood donation is avoided whenever possible. 9, 10 In terms of addressing social barriers to donating, including community members as a part of the research team alleviated many of the concerns regarding research mistrust. For example, the community members said that their community would not be uncomfortable with the idea having donated biospecimens stored indefinitely; therefore, we worked collaboratively to establish an acceptable timeframe for using the samples (10 years from the date of collection). In addition, because the most compelling reason to donate was to benefit future generations, we unanimously decided that all donated biospecimens would be used for only Asian American cancer health disparities research. Similar to the studies conducted by Gao et al in 2014 and Rodriguez et al in 2016, we discovered that individuals would be willing to donate blood biospecimens for research if they were given an opportunity to donate immediately after a biospecimen educational session. 22, 23 However, although both of those studies focused on engaging the general community and required participants to attend an in-depth (45-60 minutes) biospecimen educational seminar before donating, our approach included engaging both patients with cancer and the general community and did not require participants to attend an in-depth educational session on biospecimens. Our study provides evidence that in-depth education may not be required for communities to donate biospecimens for cancer research, and it also suggest that simply not being asked to donate is a significant barrier to donating. [9] [10] [11] [12] 
Strengths and Limitations
Despite the many strengths of our study, it does have some limitations. The participants were a convenience sample comprised of mostly foreign-born Asian American women; and, in terms of outreach, most participants were Hmong because of the large number of community biospecimen blood drives we held in the Hmong community; for in-reach, most were Chinese patients with cancer.
Conversely, relatively few of foreign-born women, particularly Hmong, are being served by mainstream health systems and are under-represented in cancer research. We attribute our success to the trust imputed to us through our collaborators and the provision of in-language services. In addition, individuals who participated in the events may have been motivated by their interest in the sponsoring organization's theme (eg, getting tested for HBV, etc); and, for patients, only those interested in learning more about biospecimens participated in the educational sessions. We also recognize that some intragroup variations may exist between those who do and do not choose to donate (ie, those who are more acculturated vs less acculturated as well as educational and socioeconomic differences). Thus, we cannot generalize our findings, because our sample may not be representative of their ethnic group. Nevertheless, the current findings are useful, because this is 1 of the first studies to collect blood biospecimens from diverse Asian Americans for cancer research. The approach we have outlined significantly increased the number of biospecimens donated by Asian Americans for cancer research and exemplifies a model approach. The more biospecimens we have from diverse populations, the closer we get to understanding the mechanism behind biologic, molecular, and cancer population research. For example, the biospecimens collected in this study have been used to characterize Asian American cancer risk factors based on clinical diagnosis (rather than self-report), 24 and the community blood biospecimens have been the basis for positing that the high frequency of the PNPLA3 rs738409 (G) single-nucleotide polymorphism may potentially explain the genetic predisposition for chronic liver disease among Hmong. 25 
Conclusions
Our approach has the potential to serve as a model for cancer centers interested in engaging diverse communities in their research endeavors. By adhering to the 3 principles of time, trust, and transparency, we were able to introduce a new concept to the community, receive their buy-in, and successfully engage them in donating biospecimens. However, to foster and nurture these relationships, community-engagement efforts need to be viewed as mutually beneficial and not as a 1-sided effort; and they also need to embrace the cultural and social values embedded in these communities. These collaborations should build community capacity not only to understand the value of research but also to advocate for their need. Researchers need to commit to investing the time necessary to develop community relationships and earn community trust by being transparent in their research motives. Our result of community responsiveness to this approach testifies to the effectiveness of what has been accomplished.
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